OpenAlex
PricingAboutJobs
Log inGet started
Work

Vandetanib as a potential treatment for breast cancer

HTML

Year: 2014
Type: review
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.2014.942034
Authors: Antonella De Luca, Amelia D’Alessio, Monica Rosaria Maiello, Marianna Gallo, Simona Bevilacqua, Daniela Frezzetti, Alessandro Morabito, Francesco Perrone, Nicola Normanno
Institution: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: vandetanib, breast cancer, VEGFR2, tumor angiogenesis, tyrosine kinase inhibitors, EGFR, RET, metastatic breast cancer, drug resistance, anti-angiogenic therapy, predictive biomarkers, pharmacokinetics, pharmacodynamics
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2109727303
FWCI: 0.15
Cites: 47
Cited by: 15
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security